IAG Wealth Partners
LEGN icon

IAG Wealth Partners’s Legend Biotech LEGN Stock Holding History

IAG Wealth Partners’s Portfolio LEGN Stock Details LEGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.9K Hold
500
– – ﹤0.01% 400
2026
Q2 		$14.4K Hold
500
– – ﹤0.01% 348
2026
Q1 		$9.04K Buy
+500
New +$9.5K ﹤0.01% 393

Other funds holding LEGN

Matthews International Capital Management
Matthews International Capital Management San Francisco, California $241M AUM 42.66% 1-Year Est. Return
Johnson & Johnson
Johnson & Johnson New Brunswick, New Jersey $762M AUM 69.66% 1-Year Est. Return
IAMH
IvyRock Asset Management (HK) Sheung Wan, Hong Kong $190M AUM 21.53% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
CenterBook Partners
CenterBook Partners Greenwich, Connecticut $2.18B AUM 12.5% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Empire Life Investments
Empire Life Investments Toronto, Ontario, Canada $1.83B AUM 33.18% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

IAG Wealth Partners's LEGN Position: Q3 2026 in Review

IAG Wealth Partners held its Legend Biotech (LEGN) position steady in Q3 2026 at 500 shares worth $9.9K. The position accounts for ﹤0.01% of the portfolio, ranked #400.

IAG Wealth Partners first reported a position in LEGN in Q1 2026 and has held it in 3 quarters since. The position peaked at $14.4K in Q2 2026. 75 funds tracked by Wall St. Rank hold LEGN as of Q3 2026.

  • IAG Wealth Partners held 500 shares of Legend Biotech worth $9.9K as of Q3 2026.
  • IAG Wealth Partners left its Legend Biotech share count unchanged in Q3 2026.
  • Legend Biotech made up ﹤0.01% of IAG Wealth Partners's portfolio in Q3 2026, its #400 holding.
  • IAG Wealth Partners first reported a position in Legend Biotech in Q1 2026 and has held it in 3 quarters since.
  • IAG Wealth Partners's Legend Biotech position peaked at $14.4K in Q2 2026.
  • 75 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2026.

Based on IAG Wealth Partners's 13F filing for Q3 2026, filed 6 Nov 2026.